12.30
price up icon1.23%   0.15
pre-market  Vorhandelsmarkt:  12.59   0.29   +2.36%
loading
Schlusskurs vom Vortag:
$12.15
Offen:
$12.16
24-Stunden-Volumen:
784.01K
Relative Volume:
3.01
Marktkapitalisierung:
$150.74M
Einnahmen:
$1.54M
Nettoeinkommen (Verlust:
$-38.70M
KGV:
-2.6338
EPS:
-4.67
Netto-Cashflow:
$-36.86M
1W Leistung:
-27.69%
1M Leistung:
-17.06%
6M Leistung:
+57.89%
1J Leistung:
-27.30%
1-Tages-Spanne:
Value
$11.64
$12.51
1-Wochen-Bereich:
Value
$11.59
$18.11
52-Wochen-Spanne:
Value
$4.64
$20.77

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
Firmenname
Corbus Pharmaceuticals Holdings Inc
Name
Telefon
617-963-0103
Name
Adresse
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
Mitarbeiter
28
Name
Twitter
@corbuspharma
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
CRBP's Discussions on Twitter

Vergleichen Sie CRBP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CRBP
Corbus Pharmaceuticals Holdings Inc
12.30 148.90M 1.54M -38.70M -36.86M -4.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-30 Fortgesetzt B. Riley Securities Buy
2025-02-28 Eingeleitet William Blair Outperform
2024-12-02 Eingeleitet Piper Sandler Overweight
2024-07-30 Eingeleitet Wedbush Outperform
2024-07-22 Fortgesetzt H.C. Wainwright Buy
2024-06-26 Eingeleitet B. Riley Securities Buy
2024-06-03 Bestätigt Oppenheimer Outperform
2024-05-13 Eingeleitet RBC Capital Mkts Outperform
2024-03-06 Hochstufung Jefferies Hold → Buy
2020-09-08 Herabstufung BTIG Research Buy → Neutral
2020-09-08 Herabstufung Jefferies Buy → Hold
2020-09-08 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2020-09-08 Herabstufung ROTH Capital Buy → Neutral
2020-07-07 Eingeleitet ROTH Capital Buy
2020-06-17 Eingeleitet BTIG Research Buy
2020-03-26 Eingeleitet Nomura Buy
2019-04-05 Eingeleitet Jefferies Buy
2019-03-20 Eingeleitet Oppenheimer Outperform
2019-01-11 Bestätigt Cantor Fitzgerald Overweight
2018-12-26 Eingeleitet H.C. Wainwright Buy
2018-12-07 Eingeleitet RBC Capital Mkts Outperform
2018-10-24 Eingeleitet B. Riley FBR Buy
2018-01-19 Eingeleitet Raymond James Outperform
2017-12-14 Bestätigt Cantor Fitzgerald Overweight
2017-11-08 Bestätigt Noble Financial Buy
2017-09-29 Fortgesetzt Noble Financial Buy
2017-03-30 Bestätigt Cantor Fitzgerald Overweight
2016-11-15 Bestätigt JMP Securities Mkt Outperform
2016-11-11 Bestätigt Noble Financial Buy
Alle ansehen

Corbus Pharmaceuticals Holdings Inc Aktie (CRBP) Neueste Nachrichten

pulisher
02:42 AM

What analyst consensus says on Corbus Pharmaceuticals Holdings Inc. stockQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - newser.com

02:42 AM
pulisher
01:52 AM

Published on: 2025-11-04 00:52:02 - newser.com

01:52 AM
pulisher
01:21 AM

Is it time to cut losses on Corbus Pharmaceuticals Holdings Inc.July 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com

01:21 AM
pulisher
Nov 03, 2025

Published on: 2025-11-03 22:12:54 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.71 a shareEarnings Preview - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top dividend aristocrat candidateMarket Volume Report & Expert Curated Trade Setup Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Corbus Pharmaceuticals Announces $70.5M Public Offering - TipRanks

Nov 03, 2025
pulisher
Nov 03, 2025

Form 424B5 Corbus Pharmaceuticals - StreetInsider

Nov 03, 2025
pulisher
Nov 03, 2025

Is Corbus Pharmaceuticals Holdings Inc. stock a contrarian buyPortfolio Performance Report & AI Forecasted Entry/Exit Points - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 05:13:38 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 05:07:17 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Quantitative breakdown of Corbus Pharmaceuticals Holdings Inc. recent move2025 Top Gainers & High Yield Stock Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Understanding Corbus Pharmaceuticals Holdings Inc.’s price movement2025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will breakout in Corbus Pharmaceuticals Holdings Inc. lead to full recoveryJuly 2025 Final Week & Pattern Based Trade Signal System - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

AlphaQuest LLC Has $218,000 Holdings in Corbus Pharmaceuticals Holdings, Inc. $CRBP - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

How institutional buying supports Corbus Pharmaceuticals Holdings Inc. stockEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Corbus Pharmaceuticals Holdings Inc. (3371) stock remain on Wall Street radarMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Short interest data insights for Corbus Pharmaceuticals Holdings Inc.Earnings Overview Summary & Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Corbus Pharmaceuticals Holdings Inc. stock reach $100 price targetIPO Watch & Low Drawdown Investment Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Corbus Pharmaceuticals Holdings Inc. stock is favored by pension fundsWeekly Profit Analysis & Technical Buy Zone Confirmations - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Can swing trading help recover from Corbus Pharmaceuticals Holdings Inc. losses2025 Support & Resistance & Stock Market Timing Techniques - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How to build a dashboard for Corbus Pharmaceuticals Holdings Inc. stockOil Prices & Growth Focused Stock Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Corbus Pharmaceuticals slumps 17%, prices $75M at $13 per share - MSN

Nov 02, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 11:47:57 - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 07:07:31 - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Comparing Corbus Pharmaceuticals Holdings Inc. in custom built stock radarsMarket Growth Report & Reliable Entry Point Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 11:30:29 - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 08:40:29 - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Corbus Pharmaceuticals provides preliminary Q3 cash estimate in SEC filing By Investing.com - Investing.com Australia

Nov 01, 2025
pulisher
Nov 01, 2025

Corbus prices $75 million public offering of common stock By Investing.com - Investing.com Philippines

Nov 01, 2025
pulisher
Oct 31, 2025

Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window (NASDAQ:CRBP) - Seeking Alpha

Oct 31, 2025
pulisher
Oct 31, 2025

Corbus Pharmaceuticals stock plunges after $75 million public offering By Investing.com - Investing.com UK

Oct 31, 2025
pulisher
Oct 31, 2025

Corbus Pharmaceuticals stock plunges after $75 million public offering - Investing.com

Oct 31, 2025
pulisher
Oct 31, 2025

Corbus Pharmaceuticals announces common stock offering By Investing.com - Investing.com Australia

Oct 31, 2025
pulisher
Oct 31, 2025

Corbus Pharmaceuticals (NASDAQ:CRBP) Share Price Passes Above 50-Day Moving AverageShould You Sell? - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Oct 31, 2025
pulisher
Oct 31, 2025

Corbus Pharmaceuticals (CRBP) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 05:15:03 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 05:14:27 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Corbus Pharmaceuticals Prices $75 Million Offering; Shares Down Pre-Bell - MarketScreener

Oct 31, 2025
pulisher
Oct 31, 2025

Corbus prices $75 million public offering of common stock - Investing.com

Oct 31, 2025

Finanzdaten der Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):